Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report.
Publication
, Journal Article
Faulkner, AL; Swanson, E; McLarney, TL; Lee, CY; Rebel, A
Published in: A A Pract
March 1, 2019
Dexmedetomidine is a selective α2-agonist, frequently used in perioperative medicine as anesthesia adjunct. The medication carries a Food and Drug Administration pregnancy category C designation and is therefore rarely used for parturients undergoing nonobstetric surgery. We are reporting the use of dexmedetomidine in the anesthetic management of a parturient undergoing minimally invasive unilateral adrenalectomy for pheochromocytoma during the second trimester of pregnancy. Additionally, because of the multiple endocrine neoplasia type 2A constellation with diagnosis of medullary thyroid cancer, the patient underwent a total thyroidectomy 1 week after the adrenalectomy.
Duke Scholars
Published In
A A Pract
DOI
EISSN
2575-3126
Publication Date
March 1, 2019
Volume
12
Issue
5
Start / End Page
136 / 140
Location
United States
Related Subject Headings
- Thyroidectomy
- Thyroid Neoplasms
- Pregnancy Complications, Neoplastic
- Pregnancy
- Pheochromocytoma
- Multiple Endocrine Neoplasia Type 2a
- Humans
- Female
- Dexmedetomidine
- Carcinoma, Neuroendocrine
Citation
APA
Chicago
ICMJE
MLA
NLM
Faulkner, A. L., Swanson, E., McLarney, T. L., Lee, C. Y., & Rebel, A. (2019). Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report. A A Pract, 12(5), 136–140. https://doi.org/10.1213/XAA.0000000000000861
Faulkner, Amanda L., Eric Swanson, Thomas L. McLarney, Cortney Y. Lee, and Annette Rebel. “Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report.” A A Pract 12, no. 5 (March 1, 2019): 136–40. https://doi.org/10.1213/XAA.0000000000000861.
Faulkner AL, Swanson E, McLarney TL, Lee CY, Rebel A. Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report. A A Pract. 2019 Mar 1;12(5):136–40.
Faulkner, Amanda L., et al. “Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report.” A A Pract, vol. 12, no. 5, Mar. 2019, pp. 136–40. Pubmed, doi:10.1213/XAA.0000000000000861.
Faulkner AL, Swanson E, McLarney TL, Lee CY, Rebel A. Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report. A A Pract. 2019 Mar 1;12(5):136–140.
Published In
A A Pract
DOI
EISSN
2575-3126
Publication Date
March 1, 2019
Volume
12
Issue
5
Start / End Page
136 / 140
Location
United States
Related Subject Headings
- Thyroidectomy
- Thyroid Neoplasms
- Pregnancy Complications, Neoplastic
- Pregnancy
- Pheochromocytoma
- Multiple Endocrine Neoplasia Type 2a
- Humans
- Female
- Dexmedetomidine
- Carcinoma, Neuroendocrine